Charcot-Marie-Tooth Association

Mission Our mission is to generate the resources to find a cure, to create awareness, and to improve the quality of life for those affected by Charcot-Marie-Tooth. The time is now: Our vision is a world without CMT! Description Charcot-Marie-Tooth, or CMT, is the most commonly inherited peripheral neuropathy and is found worldwide among all races and ethnic groups. Discovered in 1886 by three physicians, Jean-Martin Charcot, Pierre Marie, and Howard Henry Tooth, CMT affects an estimated 2.8 million people. General Information The CMTA is a 501(C)(3)nonprofit organization founded in 1983 whose goals are patient support, public education, promotion of research and ultimately the treatment and cure of CMT. A voluntary Board of Directors governs the CMTA. The Medical Advisory Board of the CMTA consists of over 50 clinical and research medical professionals. This international group of men and women are noted CMT experts in neurology, genetics, orthopedic surgery, physiatry, physical therapy and podiatry. The CMTA currently has more than 20,000 patients and families, supportive friends, and medical professionals in its database.